Trusolino, L., Bertotti, A
Intravenous infusion of up to 20 mg of BPC-157 in 2 healthy adults showed no adverse effects and was well-tolerated. Lee & Burgess, Alternative Therapies in Health and Medicine, 2025 Limitations : Only 2 participants Very short observation period No long-term follow-up No efficacy endpoints What These Studies Tell UsAnd What They Dont What We Can Reasonably Conclude Short-term tolerance appears acceptable : Across all three studies (roughly 30 participants total), no adverse events were reported
Capsules for research purpose only See more The individual capabilities of BPC 157 and TB 500 are remarkable, but their combined effects are truly extraordinary
He emphasized increased water intake, recommended more fiber-rich foods, and suggested a safe fiber supplement
Research found that combining 6% BV with chitosan improved wound healing (Zgen and Sevin, 2023)
6 FASEB Journal (PubMed)Active-site mapping of thymosin beta-4 fragments for angiogenesis and cell migration
